Entecavir and Solu-cortef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Entecavir (entecavir) and Solu-cortef (hydrocortisone sodium succinate). Common drug interactions include arthralgia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Entecavir and Solu-cortef. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

On Jul, 31, 2026

14 people who take Entecavir and Solu-cortef together, and have interactions are studied.

Entecavir and Solu-cortef drug interactions.

What are the common drug interactions of Entecavir and Solu-Cortef, by gender? *:

female:

Arthralgia (joint pain)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Heart rate decreased
Poor venous access
Skin infection
Blood pressure diastolic increased
Blood pressure increased
Erythema multiforme (a type of hypersensitivity reaction)

male:

Pyrexia (fever)

What are the common drug interactions of Entecavir and Solu-Cortef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood pressure diastolic increased
Blood pressure increased
Weight increased
Arthralgia (joint pain)
Heart rate decreased
Poor venous access
Skin infection

50-59:

Erythema multiforme (a type of hypersensitivity reaction)
Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Pyrexia (fever)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 71.43%
Hepatitis B Core Antibody Positive: 10 people, 71.43%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 21.43%
Hyperglycemia (high blood sugar): 2 people, 14.29%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 2 people, 14.29%
Back Pain: 2 people, 14.29%
B-Cell Lymphoma Recurrent (blood cancer affecting b cells-recurrent): 2 people, 14.29%
Osteoporosis (bones weak and more likely to break): 1 person, 7.14%
Organising Pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue): 1 person, 7.14%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Entecavir and Solu-cortef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously